1. Home
  2. OGN vs SAM Comparison

OGN vs SAM Comparison

Compare OGN & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • SAM
  • Stock Information
  • Founded
  • OGN 1923
  • SAM 1984
  • Country
  • OGN United States
  • SAM United States
  • Employees
  • OGN N/A
  • SAM N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • SAM Beverages (Production/Distribution)
  • Sector
  • OGN Health Care
  • SAM Consumer Staples
  • Exchange
  • OGN Nasdaq
  • SAM Nasdaq
  • Market Cap
  • OGN 2.5B
  • SAM 2.1B
  • IPO Year
  • OGN N/A
  • SAM 1995
  • Fundamental
  • Price
  • OGN $9.82
  • SAM $192.00
  • Analyst Decision
  • OGN Hold
  • SAM Hold
  • Analyst Count
  • OGN 4
  • SAM 11
  • Target Price
  • OGN $18.00
  • SAM $271.70
  • AVG Volume (30 Days)
  • OGN 3.5M
  • SAM 304.5K
  • Earning Date
  • OGN 08-05-2025
  • SAM 07-24-2025
  • Dividend Yield
  • OGN 0.81%
  • SAM N/A
  • EPS Growth
  • OGN N/A
  • SAM N/A
  • EPS
  • OGN 2.88
  • SAM 6.16
  • Revenue
  • OGN $6,294,000,000.00
  • SAM $2,040,741,000.00
  • Revenue This Year
  • OGN N/A
  • SAM $2.79
  • Revenue Next Year
  • OGN $1.11
  • SAM $2.61
  • P/E Ratio
  • OGN $3.42
  • SAM $30.98
  • Revenue Growth
  • OGN N/A
  • SAM 0.79
  • 52 Week Low
  • OGN $8.01
  • SAM $185.34
  • 52 Week High
  • OGN $23.10
  • SAM $329.55
  • Technical
  • Relative Strength Index (RSI)
  • OGN 48.62
  • SAM 36.04
  • Support Level
  • OGN $9.74
  • SAM $191.44
  • Resistance Level
  • OGN $10.27
  • SAM $200.54
  • Average True Range (ATR)
  • OGN 0.36
  • SAM 6.74
  • MACD
  • OGN -0.00
  • SAM 1.04
  • Stochastic Oscillator
  • OGN 29.78
  • SAM 29.35

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: